Functional Consequences of Mutations in Amino Acid Residues that Stabilize Calcium Binding to the First Epidermal Growth Factor Homology Domain of Human Protein C
暂无分享,去创建一个
[1] P. Handford,et al. The structure of a Ca2+-binding epidermal growth factor-like domain: Its role in protein-protein interactions , 1995, Cell.
[2] J. Birktoft,et al. High Affinity Ca2+-binding Site in the Serine Protease Domain of Human Factor VIIa and Its Role in Tissue Factor Binding and Development of Catalytic Activity (*) , 1995, The Journal of Biological Chemistry.
[3] F. Castellino,et al. Calcium and phospholipid binding properties of synthetic gamma-carboxyglutamic acid-containing peptides with sequence counterparts in human protein C. , 1994, Biochemistry.
[4] F. Castellino,et al. The activities of recombinant gamma-carboxyglutamic-acid-deficient mutants of activated human protein C toward human coagulation factor Va and factor VIII in purified systems and in plasma. , 1994, Biochemistry.
[5] F. Sussman,et al. Mutation of Glu-80-->Lys results in a protein C mutant that no longer requires Ca2+ for rapid activation by the thrombin-thrombomodulin complex. , 1994, The Journal of biological chemistry.
[6] F. Castellino,et al. Construction, expression, and properties of a recombinant chimeric human protein C with replacement of its growth factor-like domains by those of human coagulation factor IX. , 1994, Biochemistry.
[7] I. Campbell,et al. The effect of aspartate hydroxylation on calcium binding to epidermal growth factor-like modules in coagulation factors IX and X. , 1993, The Journal of biological chemistry.
[8] C. Esmon,et al. Analysis of the functions of the first epidermal growth factor-like domain of factor X. , 1993, The Journal of biological chemistry.
[9] E. Blasko,et al. The short loop between epidermal growth factor-like domains 4 and 5 is critical for human thrombomodulin function. , 1993, The Journal of biological chemistry.
[10] F. Castellino,et al. Binding of calcium to synthetic peptides containing gamma-carboxyglutamic acid. , 1993, International journal of peptide and protein research.
[11] M. Ullner,et al. How an epidermal growth factor (EGF)-like domain binds calcium. High resolution NMR structure of the calcium form of the NH2-terminal EGF-like domain in coagulation factor X. , 1994, The Journal of biological chemistry.
[12] C. Esmon,et al. The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin complex can be distinguished by mutational analysis of protein C derivatives. , 1992, The Journal of biological chemistry.
[13] J. Lin,et al. Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. , 1992, The Journal of clinical investigation.
[14] I. Campbell,et al. Ligand requirements for Ca2+ binding to EGF-like domains. , 1992, Protein engineering.
[15] F. Castellino,et al. Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity. , 1992, Blood.
[16] C. Esmon,et al. The high affinity calcium-binding site involved in protein C activation is outside the first epidermal growth factor homology domain. , 1992, The Journal of biological chemistry.
[17] F. Castellino,et al. Role of tryptophan-74 of the recombinant kringle 2 domain of tissue-type plasminogen activator in its omega-amino acid binding properties. , 1992, Biochemistry.
[18] F. Castellino,et al. Expression, purification, and characterization of the recombinant kringle 1 domain from tissue-type plasminogen activator. , 1992, Archives of biochemistry and biophysics.
[19] S. Bajaj,et al. Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[20] F. Castellino,et al. Role of the hexapeptide disulfide loop present in the gamma-carboxyglutamic acid domain of human protein C in its activation properties and in the in vitro anticoagulant activity of activated protein C. , 1991, Biochemistry.
[21] J. Walls,et al. Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin. , 1991, The Journal of biological chemistry.
[22] I. D. Campbell,et al. Key residues involved in calcium-binding motifs in EGF-like domains , 1991, Nature.
[23] P. Winship,et al. Identification of haemophilia B patients with mutations in the two calcium binding domains of factor IX: importance of a β‐OH Asp 64→Asn change , 1991, British journal of haematology.
[24] D. Monroe,et al. Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domain. , 1990, The Journal of biological chemistry.
[25] I. Campbell,et al. The first EGF‐like domain from human factor IX contains a high‐affinity calcium binding site. , 1990, The EMBO journal.
[26] D. Bentley,et al. Molecular pathology of haemophilia B. , 1989, The EMBO journal.
[27] B. Lämmle,et al. Immunoblotting studies of the molecular forms of protein C in plasma. , 1988, Thrombosis research.
[28] S. Linse,et al. Calcium binding to the epidermal growth factor homology region of bovine protein C. , 1988, The Journal of biological chemistry.
[29] S. Yamamoto,et al. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. , 1987, The EMBO journal.
[30] J. Ware,et al. Factor IXAlabama: a point mutation in a clotting protein results in hemophilia B. , 1987, Blood.
[31] Y. Sakata,et al. Conformation-specific monoclonal antibodies to the calcium-induced structure of protein C. , 1986, The Journal of biological chemistry.
[32] Thomas A. Kunkel,et al. Rapid and efficient site-specific mutagenesis without phenotypic selection. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[33] C. Esmon,et al. Proteolytic formation and properties of gamma-carboxyglutamic acid-domainless protein C. , 1983, The Journal of biological chemistry.
[34] C. Esmon,et al. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. , 1982, The Journal of biological chemistry.
[35] W. Kisiel,et al. Interaction of calcium with bovine plasma protein C. , 1981, Biochemistry.
[36] E. Davie,et al. Preparation and properties of bovine factor VIII (antihemophilic factor). , 1980, Biochemistry.
[37] W. Kisiel,et al. Anticoagulant properties of bovine plasma protein C following activation by thrombin. , 1977, Biochemistry.
[38] G. Nelsestuen. Role of gamma-carboxyglutamic acid. An unusual protein transition required for the calcium-dependent binding of prothrombin to phospholipid. , 1976, The Journal of biological chemistry.